Literature DB >> 19450357

Head injury (moderate to severe).

Ian Maconochie1, Mark Ross.   

Abstract

INTRODUCTION: Head injury in young adults is often associated with motor vehicle accidents, violence, and sports injuries. In older adults it is often associated with falls. Severe head injury can lead to secondary brain damage from cerebral ischaemia resulting from hypotension, hypercapnia, and raised intracranial pressure. Severity of brain injury is assessed using the GCS. While about a quarter of people with severe brain injury (GCS score less than 8) will make a good recovery, about a third will die, and a fifth will have severe disability or be in a vegetative state. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of interventions to reduce complications of moderate to severe head injury as defined by Glasgow Coma Scale? We searched: Medline, Embase, The Cochrane Library and other important databases up to April 2007 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 17 systematic reviews, RCTs, or observational studies that met our inclusion criteria.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: antibiotics, anticonvulsants, corticosteroids, hyperventilation, hypothermia, and mannitol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19450357      PMCID: PMC2943769     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  24 in total

1.  Improving clinical outcomes from acute subdural hematomas with the emergency preoperative administration of high doses of mannitol: a randomized trial.

Authors:  J Cruz; G Minoja; K Okuchi
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

2.  Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank.

Authors:  H M Eisenberg; H E Gary; E F Aldrich; C Saydjari; B Turner; M A Foulkes; J A Jane; A Marmarou; L F Marshall; H F Young
Journal:  J Neurosurg       Date:  1990-11       Impact factor: 5.115

Review 3.  Preventing secondary brain damage after head injury: a multidisciplinary challenge.

Authors:  D Gentleman
Journal:  Injury       Date:  1990-09       Impact factor: 2.586

Review 4.  Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures.

Authors:  B Ratilal; J Costa; C Sampaio
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 5.  Severe traumatic brain injury.

Authors:  S R Finfer; J Cohen
Journal:  Resuscitation       Date:  2001-01       Impact factor: 5.262

6.  Effects of selective brain cooling in patients with severe traumatic brain injury: a preliminary study.

Authors:  W G Liu; W S Qiu; Y Zhang; W M Wang; F Lu; X F Yang
Journal:  J Int Med Res       Date:  2006 Jan-Feb       Impact factor: 1.671

Review 7.  The use of mannitol in severe head injury. Brain Trauma Foundation.

Authors: 
Journal:  J Neurotrauma       Date:  1996-11       Impact factor: 5.269

8.  Thrombocytopenia after therapeutic hypothermia in severe traumatic brain injury.

Authors:  Wu-si Qiu; Wei-min Wang; Hong-ying Du; Wei-guo Liu; Hong Shen; Lei-fen Shen; Ming-lan Zhu
Journal:  Chin J Traumatol       Date:  2006-08

9.  Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial.

Authors:  J P Muizelaar; A Marmarou; J D Ward; H A Kontos; S C Choi; D P Becker; H Gruemer; H F Young
Journal:  J Neurosurg       Date:  1991-11       Impact factor: 5.115

10.  Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study.

Authors:  K R Smith; P M Goulding; D Wilderman; P R Goldfader; P Holterman-Hommes; F Wei
Journal:  Arch Neurol       Date:  1994-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.